ABOUT US

Luis is the Founder of Theradaptive and developed the concept for targeted regeneration platform during and following a combat tour in Iraq where several of his soldiers suffered severe extremity injuries. Previously, Luis was the co-founding Deputy Director of the Department of Defense Regenerative Medicine Program and led the department’s largest recombinant biologics program through Phase II. Luis was a DARPA Service Chief Fellow and Academy Professor at the United States Military Academy, West Point. Luis received his PhD in Biological Engineering from MIT where he was a Hertz Foundation Fellow.

With over 25 years of diverse regulatory experience spanning medical devices, biologics, and pharmaceuticals, Joe Tamayo brings a comprehensive background in Class III implantable devices and combination technologies. He has successfully guided products through the entire “concept to market” lifecycle, providing strategic regulatory and quality support for both domestic and international markets. A proven expert in virtual quality systems and Quality Management Representation, Joe has been a key member of multiple executive management teams, contributing across regulatory, quality, clinical, and operational functions. Joe currently serves as Vice President of Regulatory and Quality at Theradaptive.

Ed Fix serves as the VP of Manufacturing at Theradaptive. He has over 20 years of experience in biotechnology manufacturing, spanning preclinical, clinical trial and commercial production, across a broad range of products including recombinant proteins, monoclonal antibodies, vaccines, virus like proteins, and viral vectors. He has also helped establish pilot plant and commercial facilities at a number of companies and has successfully represented production team during global regulatory inspections. Previously, he was the Director of Manufacturing at IDT Biologika’s US based Rockville Site. He has held positions of increasing responsibility at Novavax, GlaxoSmithKline and Human Genome Sciences, Inc. Ed earned his Bachelor of Science in Biology and Chemistry Minor at Virginia Polytechnic Institute and State University.

With over 20 years of experience in biotech product development, David serves as Chief Operating Officer at Theradaptive and oversees daily operations and R&D at the Frederick headquarters. Previously, he was a Senior Director of Product Development at Meso Scale Discovery where he was responsible for the development of hundreds of multiplex immunoassay products including three flagship product lines. David received his PhD in Biophysical Chemistry from Yale University.

Brian Wong serves as the VP of Commercial Development at Theradaptive. He has over 20 years of experience in healthcare business strategy across medical technology and devices, diagnostics, clinical analytics, cell therapy and rare diseases. As a stock analyst, he helped bring several medical technology companies public before transitioning into various strategic roles within the healthcare industry including time at Johnson & Johnson, Boston Scientific, Philips Healthcare, and Sigilon Therapeutics where he worked on acquisitions, partnerships, and launching new products. He received his bachelor’s degree in Bioengineering from the University of Pennsylvania and a Master’s of Science in Engineering and a Master’s of Engineering Management from the Thayer School of Engineering at Dartmouth College.

Frank Vizesi, PhD, currently serves as Theradaptive’s Chief Scientific Officer. Frank is a recognized leader in the translation of research into product development and successful commercialization. He has dedicated his career to the field of bone healing and integration with orthopedic and spinal implants. Through his previous roles at high growth spine companies, NuVasive and SeaSpine, he was directly responsible for more than a dozen product launches in the osteobiologics space alone and contributed to dozens more across various disciplines. He most recently served as the Chief Scientific Officer of Orthofix, a large multinational orthopedic medical device company. Frank earned his PhD in Biomedical Engineering from the University of New South Wales, Sydney Australia.

Jonathan Elsner, PhD, brings nearly two decades of expertise in the medical device industry to his role as the Vice President of Clinical Operations at Theradaptive. With a diverse background spanning R&D and Clinical Research, Jonathan has made significant contributions to various fields including sports medicine, arthroplasty, soft tissue repair, and cardiovascular health.

Throughout his career, Jonathan has spearheaded complex clinical projects at organizations such as Active Implants LLC, Regentis Biomaterials LTD, Colospan LTD, and BrioHealth Solutions Inc. His leadership has been instrumental in guiding clinical strategy and operations from trial design to regulatory and reimbursement efforts.

Jonathan holds a PhD in Biomedical Engineering from Tel-Aviv University and an MBA from the Massachusetts Institute of Technology.